OR WAIT null SECS
July 20, 2023
Novartis’ acquisition of biotech company DTx Pharma boosts its neuroscience pipeline and expands its capabilities in RNA-based therapeutics.
These recommendations will keep key antibiotics for respiratory infections available when they are needed most.
July 14, 2023
German manufacturer metabion is conducting a multi-million euro expansion of its oligonucleotide manufacturing capacity in Munich East.
July 13, 2023
The agency is reviewing the medicines after receiving reports of self-injury and suicidal thoughts in patients using the type 2 diabetes treatments.
July 07, 2023
Camena Bioscience has completed $10 million in Series A financing on the back of growing demand for DNA synthesis.
Eurofins Genomics Blue Heron’s novel mRNA synthesis service is designed for customizable applications.
July 06, 2023
EMA, the European Commission, and HMAs are phasing out the flexible regulations put into place during the pandemic.
Full Marketing Authorization has been granted for Novavax’s COVID-19 vaccine by the European Commission.
Meletios Therapeutics has been awarded with funding worth €1.2 million (US$1.3 million) from Bpifrance’s Deeptech development program.
Syngene has acquired a multi-modal biologics drug substance manufacturing facility in Bangalore, India, from Stelis Biopharma.